Shares of Moderna slid by 4.9% to $93.15 at 21:05 UTC on Tuesday, on what proved to be an all-around rough exchanging session for Nasdaq Stock Market that also slid by 0.26% to $11893.1.
Moderna closed at $97.95, below its 52-week high of $103.2.
Moderna’s sales growth is 1074.4% for the ongoing quarter and 2299% for the next. The company’s growth estimates for the present quarter is a negative 75.7% and 142.9%, respectively.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $93.15, below its 52 Week High of $103.2 way above its 52 Week Low of $17.68.
Moderna’s worth is way higher than its 50 day moving average of $73.62 and way above its 200 day moving average of $68.29.